ASAM Drug Testing Pocket Guide

Drug Testing Pocket Guide

ASAM Opioid Addiction Treatment GUIDELINES Apps and Pocket Guides brought to you courtesy of Guideline Central. Enjoy!

Issue link:

Contents of this Issue


Page 4 of 35

5 Part 2: Process of Drug Testing in Addiction Treatment Choosing a Test Clinical Necessity and Value Î Before choosing the type of test and matrix, providers should determine the questions they are seeking to answer and familiarize themselves with the benefits and limitations of each test and matrix. Î Test selections should be individualized based on specific patients and clinical scenarios. • Patients' self-reported substance use can help guide test selection. Identifying Substance(s) of Interest Î Drug testing panels should be based on the patient's drug of choice, prescribed medications, and drugs commonly used in the patient's geographic location and peer group. Î Addiction treatment programs/providers should establish a routine immunoassay panel. • Providers should not rely on the NIDA 5 (also known as the SAMHSA 5) as a routine drug panel. Î Test panels should be regularly updated based on changes in local and national substance use trends. Providers should collaborate with the testing laboratory when determining the preferred test selections to obtain information about local and demographic trends in substance use. Matrix Advantages and Disadvantages Î Providers should understand the advantages and disadvantages of each matrix before considering rotational strategies. Î If a particular specimen cannot be collected (e.g., due to baldness, dry mouth, shy bladder), providers should consider collecting an alternative specimen. Î If a given sample is likely to be prone to confounds, providers should choose an alternative matrix. For example, heavily chemically treated hair is not appropriate for drug testing. Presumptive and Definitive Tests Î Presumptive testing should be a routine part of initial and ongoing patient assessment. Î Presumptive testing should be used when it is a priority to have more immediate (although less accurate) results. Î Providers should know the cutoff threshold concentrations that their laboratory uses when interpreting a report of "no drug present."

Articles in this issue

Archives of this issue

view archives of ASAM Drug Testing Pocket Guide - Drug Testing Pocket Guide